Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-12
SponsorUniversity of Thessaly

About this trial

This is a prospective, single-center, two-arm (1:1), assessor-blinded, randomized controlled clinical trial that will be conducted in collaboration with the outpatient clinic of the third Pediatric Pulmonology Unit, "Attikon" University Hospital of Athens in Greece. The aim of the study is to investigate the effects of applying digital physiotherapy services in the management of specific clinical outcomes in children with chronic suppurative lung diseases, other than cystic fibrosis. The research question is whether airway clearance techniques and exercise training that are performed remotely using digital health services (DHSs) can improve functional and exercise capacity, as well as compliance with ACTs, compared to usual care. The intervention program includes airway clearance techniques (ACTs), as well as aerobic and strengthening exercises that can be implemented easily in an online setting at home with minimal equipment. The duration of the program will be 12 weeks, and the prescribed weekly regimen will consist of 50-minute remote sessions: two synchronous, supervised sessions conducted via the Vsee platform, and a minimum of one asynchronous, unsupervised session. Children will be encouraged to maintain daily adherence to the exercise protocol.

Eligibility criteria

Qualifiers

children aged 6 to 12 years old

clinically stable with an absence of pulmonary exacerbation four weeks prior to the study's recruitment

adherence to attend regular medical follow-up from a pediatric pulmonologist every three months

Disqualifiers

Cystic fibrosis

Immunodeficiency or asthma as their primary condition

Clinical evidence of cardiovascular, neuromuscular, metastatic, or psychiatric comorbidities, and neuromuscular or musculoskeletal impairments that affect mobility and the ability to follow instructions

Medical history of lung transplant

Trial design

Treatments tested in this trial

  • Videoconferencing (Vsee platform)
  • Specially designed website (FysΑΩ)

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Thessaly

Lead sponsor

Attikon Hospital

Collaborator